Next Article in Journal
Isolation and Purification of a Novel Deca-Antifungal Peptide from Potato (Solanum tuberosum L. cv. Jopung) Against Candida albicans
Previous Article in Journal
Development of 16 Microsatellite Markers for Prince’s Pine, Chimaphila japonica (Pyroleae, Monotropoideae, Ericaceae)
Int. J. Mol. Sci. 2012, 13(4), 4009-4020; doi:10.3390/ijms13044009
Article

Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk

* ,
,
,
 and
Received: 16 February 2012; in revised form: 12 March 2012 / Accepted: 15 March 2012 / Published: 23 March 2012
View Full-Text   |   Download PDF [188 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: Folic acid and methylenetetrahydrofolate reductase (MTHFR) may affect the development of human cancer. However, few studies have evaluated folate intake and MTHFR in susceptibility to and prognosis of patients with ovarian cancer. We conducted a prospective case-control study in 215 ovarian cancer patients and 218 controls (all Chinese) between Jan. 2004 and Jan. 2007. MTHFR C677T genotyping was done by PCR-RFLP. All patients were followed up until Dec. 2010. We found a 2.43-fold increased risk of ovarian cancer among MTHFR 677TT carriers, and a decreased risk of ovarian cancer in individuals with high folate intake (OR = 0.54, 95% CI = 0.32–0.94). Cox regression survival analysis showed that among the ovarian cancer patients, those carrying the 677TT genotype had a higher risk of death (HR = 2.17, 95% CI = 1.20–4.79), while high folate intake was associated with a lower risk of death (HR = 0.43, 95% CI = 0.33–0.88). Moreover, MTHFR 677CC carriers with higher folate intake showed a lower risk of death from ovarian cancer (HR = 0.32, 95% CI = 0.27–0.82). In summary, high folate intake may lessen susceptibility and improve the prognosis of ovarian cancer patients, while the MTHFR 677TT genotype appears to increase ovarian cancer risk and worsen its prognosis in a Chinese population.
Keywords: folate; methylenetetrahydrofolate reductase gene; polymorphism; ovarian cancer risk folate; methylenetetrahydrofolate reductase gene; polymorphism; ovarian cancer risk
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Zhang, L.; Liu, W.; Hao, Q.; Bao, L.; Wang, K. Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk. Int. J. Mol. Sci. 2012, 13, 4009-4020.

AMA Style

Zhang L, Liu W, Hao Q, Bao L, Wang K. Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk. International Journal of Molecular Sciences. 2012; 13(4):4009-4020.

Chicago/Turabian Style

Zhang, Li; Liu, Wenxin; Hao, Quan; Bao, Lewen; Wang, Ke. 2012. "Folate Intake and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Predictive and Prognostic Biomarkers for Ovarian Cancer Risk." Int. J. Mol. Sci. 13, no. 4: 4009-4020.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert